Digitalization of Health Care: Tracking and Treatment Evaluation
Roberto Pasti
Enterprise Account Executive - Software, Cloud, Digital Manufacturing, Sensors, IoT, Embedded Systems
The healthcare industry benefited from the IT adoption. But they struggled to successfully manage stakeholders, regulations, and privacy concerns required to build a fully integrated digital healthcare model.
Patients around the world have grown more comfortable using digital networks and services. I believe the time has come for healthcare systems and providers to re-think their digital strategies.
Health Tracking
It’s the Uber-ization of life, and a growing cadre of patients-cum-health consumers are calling for more convenient, accessible, and lower-cost health care solutions. Self-care at home using digital health tech is much happier prospect for this new healthcare consumer.
Apple just introduced its most ambitious health product yet, an open-source app development platform called “CareKit.” It’s basically a way to help people keep track of their medical treatment, and to share information with doctors remotely.
Other apps monitors a person's voice during phone calls to detect mood changes in people who have bipolar disorder. New drug-sensor-app systems tracks when a pill is been taken. Band Aid-like sensor, worn on the body, that knows when a tiny chip hidden inside a pill is swallowed—so if patients aren’t keeping up with their meds, the program can alert their doctors.
We need to have specific, targeted communication tailored on the behalf of the patients / customers and we need to have a software/ database which allows us to get the main facts out of the ?big data“. Which is at the end – no real news! – but important for the next steps.
Not only medication can be efficient and effective. Patient adherence, less re- admissions in hospitals are relevant to value health outcomes for patients. What we can see is the trend in R&D to specialty drugs, smaller patient groups, different forms of therapy regimen, speciality drugs are more tailored to specific diseases. Treatment regimens are going to be more complex. Speciality drugs require different ?GTM‘, patient focus, less product focus, patient education to support treatment regimen and treatment surveillance.
Patients are much more educated than we expect and are using online information. Tracking of patients medication is vital for healthcare in the future. People and patients are more open to know about their healthcare.